| |
|
|
|
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
October 6, 2015 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend?
This course is intended for professionals in the cosmetic and personal care industry, pharmaceutical skin care and skin care related medical devices.
It will be especially valuable for:
• Professionals with background in Biology and Dermatology who wish to
design clinical trials to illustrate the visible benefits of a topical
product containing ingredients of proven biochemical, molecular efficacy
• Formulation chemists
• Professionals committed to Marketing/ Sales/ Product Development and
Communication Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
| Paolo Giacomoni, Ph.D.; Consultant to the Skin Care Industry |
Dr. Paolo Giacomoni, Ph.D. and consultant to the Skin Care Industry, is formerly VP of Skin Care World Wide Research and Development with Herbalife. He has been a quality-focused leader with over 20 years of experience in product research and development for cosmetic product providers. While at Herbalife, he had been responsible for preparing new Skin Care lines related to healthy skin, aging skin, discoloration and acne. Previously, Dr. Giacomoni was with Estée Lauder as their Executive Director, Research, for 13 years. During that time he was in charge of research and communications for Clinique and interacted with beauty editors for best-selling products such as Youth Surge, Turnaround Concentrate, Anti- Gravity, Moisture Surge Extra, Advanced Stop Signs, and Repairwear Night/Day. During his 13 years at L’Oreal as Head of the Department of Biology and as Consultant to the Director of R&D, he built a distinguished record of achievement through his work in research, testing and integrating new technologies as part of the product development process.
Dr. Giacomoni is fluent in French, Italian, German, Spanish and English and is the author of 100+ publications and patents representing breakthrough industry concepts. He received his Ph.D., Doctorat d’Etat in Biochemistry from UNIVERSITÉ PARIS VI, Paris France; his Masters Degree, Laurea in Atomic Physics from UNIVERSITÁ DI MILANO, Milano, Italy and has had Post-Doctoral Training at DEUTSCHES KREBSFORSCHUNGSZENTRUM at Heidelberg, Germany, UNIVERSITY OF WISCONSIN, Madison, WI and UNIVERSITY OF CALIFORNIA, San Diego, CA.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|
In the Cosmetic and Personal care market, almost every product is claimed to offer surprising benefits, when not magic results. Often it is stated that the results have been obtained in vitro, or that the results originate from the self-evaluation of an undetermined number of volunteers, or that the results are statistically significant. The important for a skin care product is to quickly offer visible benefits. It is therefore important to select the endpoint of clinical trials to provide evidence that an ingredient, proven in vitro to have certain biochemical properties, visibly improves the condition of the skin.
In this 90-minute accredited online session we will review the legitimate and non-legitimate extrapolations from in vitro results to the in vivo situation and we will evoke examples of successful clinical results designed to illustrate the properties of an ingredient with rigorously proven in vitro effects. We will also discuss the meaning of statistical significance versus relevance, we will evoke the Zero hypothesis and we will illustrate different ways to interpret the data obtained with groups of individuals with large inter-individual variability. This course will not enter the study of the statistical analysis of the results.